Osteosarcoma is the bone tumor that most commonly affects children, adolescents, and young adults. Before 1970, treatment primarily included surgical resection. However, the introduction of ...

Backed by a $15 million investment, families, funders, and researchers unite to advance long-awaited breakthroughs against this deadly childhood bone cancer "This Break Through Cancer project brings a ...

CLEVELAND — There's certainly something to be said for being in the right place at the right time. Dr. Alex Huang overheard a conversation between colleagues discussing a new type of drug being tested ...

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. While genetic ...

Human bone marrow under the microscope. UC Davis researchers have developed engineered bone marrow, which can be used to study treatments for osteosarcoma, one of the deadliest cancers in humans and ...

Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could ...

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient's immune cells to target cancer cells. While successful in some types of leukemia, the approach has yet to realize its ...

Immunotherapy is a type of cancer treatment. Some forms of this treatment may help treat bone cancer. However, experts need to conduct more research into immunotherapy for primary bone cancer. Primary ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, ...